96. Crohn disease Clinical trials / Disease details
Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03623932 (ClinicalTrials.gov) | November 13, 2018 | 4/7/2018 | Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease | Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease | Crohn Disease | Drug: immunosuppressor/TNFalpha;Behavioral: Hypnosis | University Hospital, Grenoble | NULL | Recruiting | 18 Years | 65 Years | All | 40 | N/A | France |